Non-high-density Lipoprotein Cholesterol for Secondary Prevention after Minor Stroke.
作者信息
Wang Yanan, Jiang Zhixuan, Wu Simiao
机构信息
Department of Neurology, West China Hospital, Sichuan University.
Center of Cerebrovascular Diseases, West China Hospital, Sichuan University.
出版信息
J Atheroscler Thromb. 2025 Feb 1;32(2):122-124. doi: 10.5551/jat.ED272. Epub 2024 Nov 16.
Abstract
摘要
相似文献
1
Non-high-density Lipoprotein Cholesterol for Secondary Prevention after Minor Stroke.非高密度脂蛋白胆固醇用于轻度卒中后的二级预防。
J Atheroscler Thromb. 2025 Feb 1;32(2):122-124. doi: 10.5551/jat.ED272. Epub 2024 Nov 16.
2
[The association of lipid profile and bleeding in patients with minor stroke or transient ischemic attack on antiplatelet therapy: subgroup analysis of CHANCE].[小卒中或短暂性脑缺血发作患者抗血小板治疗中血脂水平与出血的相关性：CHANCE亚组分析]
Zhonghua Nei Ke Za Zhi. 2018 Oct 1;57(10):723-730. doi: 10.3760/cma.j.issn.0578-1426.2018.10.006.
3
Non-high-density lipoprotein cholesterol: an important predictor of stroke and diabetes-related mortality in Japanese elderly diabetic patients.非高密度脂蛋白胆固醇：日本老年糖尿病患者卒中及糖尿病相关死亡的重要预测因子。
Geriatr Gerontol Int. 2012 Apr;12 Suppl 1:18-28. doi: 10.1111/j.1447-0594.2011.00809.x.
4
Predictive value of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio for the prevention of stroke recurrence in Japanese patients treated with rosuvastatin.载脂蛋白 B/载脂蛋白 A1 比值对瑞舒伐他汀治疗的日本患者卒中复发的预测价值。
Clin Drug Investig. 2012 Aug 1;32(8):513-21. doi: 10.1007/BF03261902.
5
Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.降低“极高”ASCVD 风险患者的靶向致动脉粥样硬化脂蛋白胆固醇目标。
Curr Diab Rep. 2019 Nov 21;19(12):146. doi: 10.1007/s11892-019-1246-y.
6
Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and the risk of post-stroke depression: A cross-sectional study.非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值（NHHR）与卒中后抑郁风险的关系：一项横断面研究。
J Stroke Cerebrovasc Dis. 2024 Nov;33(11):107991. doi: 10.1016/j.jstrokecerebrovasdis.2024.107991. Epub 2024 Sep 1.
7
Oxidized low-density lipoprotein (LDL) and LDL cholesterol are associated with outcomes of minor stroke and TIA.氧化型低密度脂蛋白（LDL）和 LDL 胆固醇与小卒中及 TIA 的结局相关。
Atherosclerosis. 2020 Mar;297:74-80. doi: 10.1016/j.atherosclerosis.2020.02.003. Epub 2020 Feb 19.
8
Genetic determinants of blood lipids and cerebral small vessel disease: role of high-density lipoprotein cholesterol.血脂和脑小血管病的遗传决定因素：高密度脂蛋白胆固醇的作用。
Brain. 2020 Feb 1;143(2):597-610. doi: 10.1093/brain/awz413.
9
Association between Non-high-density Lipoprotein Cholesterol to High-density Lipoprotein Cholesterol Ratio (NHHR) and Stroke among Adults in the USA: A Cross-Sectional NHANES Study.美国成年人中非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值（NHHR）与中风之间的关联：一项横断面的美国国家健康与营养检查调查（NHANES）研究
Biomed Environ Sci. 2025 Jan 20;38(1):37-46. doi: 10.3967/bes2025.001.
10
Increased microvascular permeability and low level of low-density lipoprotein cholesterol predict symptomatic intracerebral hemorrhage in acute ischemic stroke.微血管通透性增加和低水平的低密度脂蛋白胆固醇可预测急性缺血性脑卒中的症状性颅内出血。
Sci Prog. 2020 Apr-Jun;103(2):36850420924153. doi: 10.1177/0036850420924153.
本文引用的文献
1
Non-HDL-C, Symptomatic Intracranial Arterial Stenosis, and Recurrent Vascular Risk in Minor Stroke.非高密度脂蛋白胆固醇、症状性颅内动脉狭窄与轻度卒中的复发性血管风险
J Atheroscler Thromb. 2025 Feb 1;32(2):141-162. doi: 10.5551/jat.64987. Epub 2024 Sep 4.
2
The Influence of Non-High-Density Lipoprotein Cholesterol on the Efficacy of Genotype-Guided Dual Antiplatelet Therapy in Preventing Stroke Recurrence.非高密度脂蛋白胆固醇对基因导向双重抗血小板治疗预防卒中复发疗效的影响
J Stroke. 2024 May;26(2):231-241. doi: 10.5853/jos.2024.00367. Epub 2024 May 30.
3
Ninety-Day Stroke Recurrence in Minor Stroke: Systematic Review and Meta-Analysis of Trials and Observational Studies.90 天内小中风复发：试验和观察性研究的系统评价和荟萃分析。
J Am Heart Assoc. 2024 May 7;13(9):e032471. doi: 10.1161/JAHA.123.032471. Epub 2024 Apr 19.
4
Dual Antiplatelet Treatment up to 72 Hours after Ischemic Stroke.缺血性脑卒中后 72 小时内的双联抗血小板治疗。
N Engl J Med. 2023 Dec 28;389(26):2413-2424. doi: 10.1056/NEJMoa2309137.
5
Neuroprotective approach in acute ischemic stroke: A systematic review of clinical and experimental studies.急性缺血性卒中的神经保护方法：临床和实验研究的系统评价
Brain Circ. 2022 Dec 6;8(4):172-179. doi: 10.4103/bc.bc_52_22. eCollection 2022 Oct-Dec.
6
Lipid Lowering Therapy: An Era Beyond Statins.降脂治疗：超越他汀类药物的时代。
Curr Probl Cardiol. 2022 Dec;47(12):101342. doi: 10.1016/j.cpcardiol.2022.101342. Epub 2022 Jul 31.
7
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society.富含甘油三酯的脂蛋白及其残粒：代谢见解、在动脉粥样硬化性心血管疾病中的作用及新兴治疗策略——欧洲动脉粥样硬化学会共识声明。
Eur Heart J. 2021 Dec 14;42(47):4791-4806. doi: 10.1093/eurheartj/ehab551.
8
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association.《2021年卒中与短暂性脑缺血发作患者卒中预防指南：美国心脏协会/美国卒中协会指南》
Stroke. 2021 Jul;52(7):e364-e467. doi: 10.1161/STR.0000000000000375. Epub 2021 May 24.
9
"Minor" stroke: not a minor, still open question.“轻度”中风：并非轻度，仍是悬而未决的问题。
J Thromb Thrombolysis. 2020 Jan;49(1):132-135. doi: 10.1007/s11239-019-02001-w.
Zotero 插件